Bo Peng
About Bo Peng
Bo Peng serves as the Senior Director and Head of Intellectual Property at Wave Life Sciences, where he leads global patent and trademark strategies and provides strategic counseling on IP issues. With extensive experience in the pharmaceutical sector, he has held various roles in intellectual property and medicinal chemistry across several companies.
Current Role at Wave Life Sciences
Bo Peng serves as the Senior Director and Head of Intellectual Property at Wave Life Sciences, a position he has held since 2020. In this role, he leads the implementation of the company's global patent and trademark portfolio strategies. He provides strategic counseling on the competitive intellectual property landscape for both platform and product IP. Additionally, he advises senior management on key IP issues and organizes regular IP strategy meetings with the Executive Team.
Previous Experience in Intellectual Property
Before his current role, Bo Peng worked at Wave Life Sciences as the Director of Intellectual Property from 2019 to 2020. He also served as a Patent Agent/Patent Analyst II at Editas Medicine from 2014 to 2019. His earlier experience includes positions at Ironwood Pharmaceuticals, where he worked as a Senior Associate in Patent and Information Analysis from 2011 to 2014, and as a Medicinal Chemist from 2007 to 2011. He began his career at Millennium Pharmaceuticals as a Medicinal Chemist from 2004 to 2006.
Education and Qualifications
Bo Peng holds a Bachelor's degree in Chemistry from Peking University, where he studied from 1995 to 1999. He furthered his education at North Carolina State University, earning a Master of Science (M.S.) in Chemistry from 1999 to 2002. He became a registered Patent Agent in 2009 after completing his studies at the USPTO. His academic background supports his expertise in intellectual property and related fields.
Expertise in Intellectual Property and Strategy
Bo Peng specializes in integrating intellectual property advice with business insights and sound judgment. His expertise encompasses competitive intelligence and patent landscape analysis, where he has established cost-effective procedures. He has played a key role in significant collaborations, such as the GSK/Wave partnership, leading IP due diligence and technology assessments. He manages a team of internal and external counsels to ensure the efficient execution of patent strategies.
Technical Expertise and Specializations
Bo Peng's technical expertise includes a focus on oligonucleotides, antisense technology, RNA interference (RNAi), ADAR, RNA-editing, cell therapy, CRISPR/Cas9, gene editing, gene therapy, and viral delivery. His knowledge in these areas supports his role in advising on collaboration, licensing, and other agreements within the field of intellectual property.